DE602005010430D1 - Verfahren zur isolierung von paclitaxel - Google Patents

Verfahren zur isolierung von paclitaxel

Info

Publication number
DE602005010430D1
DE602005010430D1 DE602005010430T DE602005010430T DE602005010430D1 DE 602005010430 D1 DE602005010430 D1 DE 602005010430D1 DE 602005010430 T DE602005010430 T DE 602005010430T DE 602005010430 T DE602005010430 T DE 602005010430T DE 602005010430 D1 DE602005010430 D1 DE 602005010430D1
Authority
DE
Germany
Prior art keywords
dialkyl
paclitaxel
less polar
insulation
ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005010430T
Other languages
English (en)
Inventor
Martin Buchta
Ladislav Cvak
Roman Sobotik
Pavel Stverka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Ivax Pharmaceuticals sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Pharmaceuticals sro filed Critical Ivax Pharmaceuticals sro
Publication of DE602005010430D1 publication Critical patent/DE602005010430D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602005010430T 2004-07-02 2005-07-01 Verfahren zur isolierung von paclitaxel Expired - Fee Related DE602005010430D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58540104P 2004-07-02 2004-07-02
PCT/US2005/023543 WO2006014356A1 (en) 2004-07-02 2005-07-01 Process for the isolation of paclitaxel

Publications (1)

Publication Number Publication Date
DE602005010430D1 true DE602005010430D1 (de) 2008-11-27

Family

ID=35045368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010430T Expired - Fee Related DE602005010430D1 (de) 2004-07-02 2005-07-01 Verfahren zur isolierung von paclitaxel

Country Status (10)

Country Link
US (1) US20090216031A1 (de)
EP (1) EP1765802B1 (de)
JP (1) JP2008505111A (de)
KR (1) KR20070041547A (de)
AT (1) ATE411304T1 (de)
DE (1) DE602005010430D1 (de)
ES (1) ES2315890T3 (de)
PL (1) PL1765802T3 (de)
PT (1) PT1765802E (de)
WO (1) WO2006014356A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000023070A1 (en) * 1998-10-20 2000-04-27 Ben Venue Laboratories, Inc. Process for purification of solvents useful in the preparation of pharmaceutical compositions
US6469186B1 (en) * 2000-11-08 2002-10-22 Actipharm, Inc. Process for mass production of GMP paclitaxel and related taxanes
US6333419B1 (en) * 2000-11-28 2001-12-25 Indena Spa Chromatographic separation method of paclitaxel and cephalomannin

Also Published As

Publication number Publication date
JP2008505111A (ja) 2008-02-21
WO2006014356A1 (en) 2006-02-09
EP1765802A1 (de) 2007-03-28
ATE411304T1 (de) 2008-10-15
KR20070041547A (ko) 2007-04-18
EP1765802B1 (de) 2008-10-15
ES2315890T3 (es) 2009-04-01
PL1765802T3 (pl) 2009-04-30
PT1765802E (pt) 2008-11-25
US20090216031A1 (en) 2009-08-27

Similar Documents

Publication Publication Date Title
Campos et al. A general synthesis of substituted indoles from cyclic enol ethers and enol lactones
NO20064735L (no) Forbedret proteinekspresjonsutbytte i cellefrie proteinsyntesesystemer ved tilsats av antiskumforbindelser
DE602005021684D1 (de) Verfahren zur herstellung von pimecrolimus
TW200833651A (en) Processes suitable for producing macromolecular antioxidant compositions
DK1888541T3 (da) Benzo(d)isoxazol-3-yl-amin-forbindelser og anvendelse af disse som vanilloidreceptorligander
NO20090056L (no) Blanding for forbedret skumming ved ekstraksjon av petroleum eller naturgass
DE602005027015D1 (de) Verfahren zur Herstellung alkylierter aromatischer Zusammensetzungen
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
WO2011077099A3 (en) Methods for the purification of cucurbituril
IL175634A0 (en) Methods of preparing olanzapine
ATE515498T1 (de) Verfahren zur aufreinigung von montelukast und dessen aminsalzen
ATE535609T1 (de) Verfahren zur herstellung von (2r,3s)-1,2-epoxy-3-(geschütztes)amino-4-substi uiertem butan und zwischenstufen davon
MX2009006750A (es) Derivados de azaadamantano espirociclicos y metodos de uso.
CL2012001648A1 (es) Composicion saborizante de maillard que comprende una fase lipidica estructurada donde el solvente o mezcla de solvente polar no es agua, al menos un producto de reaccion de maillard; proceso de elaboracio que comprende hacer una fase lipidica estructurada de una fase lipidica continua de un lipido y una fase de solvente polar que no es agua, con un primer y segundo reactivo que tiene un grupo carbonilo libre y grupo amino disponible.
DE602006009901D1 (de) Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin
Tokuda et al. Remarkable switch of regioselectivity in epoxide ring opening of 3-benzyl-7-oxa-3-azabicyclo [4.1. 0] heptane with amines: practical synthesis of trans-4-amino-3-hydroxypiperidines and trans-3-amino-4-hydroxypiperidines
WO2006079057A3 (en) Methods and compositions for specific inhibition of protein splicing by small molecules
Hensbergen et al. An expedient synthesis of oxazepino and oxazocino quinazolines
DE602005025155D1 (de) Anwendung von zentrifugaler verteilungschromatographie zur aufreinigung von galanthamine
Mari et al. Facile, Odourless, Quantitative Synthesis of 3‐Hydroxy‐3, 4‐dihydro‐2H‐1, 4‐thiazines
Li et al. Quick access to the core of mersicarpine through an SNAr strategy
DE602005010430D1 (de) Verfahren zur isolierung von paclitaxel
DE602006003744D1 (de) Verfahren zur rückgewinnung von lösungsmitteln
WO2003040402A3 (en) Alpha-helix mimicry by a class of organic molecules
SA112330844B1 (ar) عملية لإعادة استخلاص حمض ميثاكريليك من طور عالي الغليان وطور مائي

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee